Clinical Trial: Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML
Study Status: Completed
Recruit Status: Completed
Condition:
Relapsed Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
Gene Abnormality
Cy
Study Type: Observational
Official Title: Influence of Molecular Abnormalities on Treatment Response of the Regimen of Venetoclax Plus Azacytidine Combined With Homoharringtonine Versus Venetoclax Plus Hypomethylating Agents (HMA) in Relapsed
Brief Summary:
The aim of this study is to reveal the influence of gene mutations on the treatment response of the regimen of HHT combined with Venetoclax plus AZA versus venetoclax plus HMA in the salvage therapy of RR-AML.
Read more